Sweden and India have a long tradition of cooperation in the field of health. From a cooperation based on development aid, the collaboration has evolved to a more dynamic and mutually beneficial alliance. Sweden has a lot to offer India when it comes to organizing healthcare be it creating a system for healthy mothers and babies, offering universal coverage to its population or care of the elderly. India is also emerging as a hub for cost-effective R & D and clinical trials. Could Indian and Swedish companies collaborate to find solutions in some important areas of Life Science?  Will have a focus on non-communicable diseases like Diabetes/ cancer/ cardio-vascular where the focus will be on the business of science.

SPEAKERS/PANELISTS
Dr. Rajiv Modi – Chairman and Managing Director of Cadilla Pharmaceuticals
Dr. Rupali Basu – President and Chief Executive Officer of Apollo Hospitals Group
Peter Bramberg – Chairman of Biomatcell Vinn Excellence Center in Biomaterials and Celltherapy
Prof Goran Hansson – Professor at Karolinska Institute and Permanent Secretary-elect of the Royal Swedish Academy of Sciences
Maria Helling – CEO for Swecare
Prof. Ingrid Lundberg – Professor at Karolinska Institute & head of Rheumatology at the Karolinska Hospital

MODERATOR: Dr. Carani Sanjeevi – Associate Professor at Karolinska Institute